Creating Waves of Awareness
A case presentation of progressive myoclonic epilepsy, recently diagnosed by a pediatric neurophysician probably as neurological ceroid lipofuscosis in a child aged around seven years old.
To begin, this child developed seizures at the age of 3-4 years old, then followed the mental detoriation with paralysis and muscle wasting of all limbs and loss of speech.
Presently, the child has repeated respiratory tract infections, and more recently for a few days, a loud wheeze with difficulty in swallowing even liquids.
The pediatrician failed to give any relief to these symptoms. I had prescribed antimonium tart LM based upon present respiratory complaints, which gave him relief. The child is better with respect to his respiratory complaints, but now we have to deal with his myoclonic epilepsy/neurological ceroid lipofuscosis. The details of this case are as follows:
To summarize, the following points are important
Pediatric neurophysician has diagnosed this condition as Neurological ceroid lipofuscinosis.
Medscape | The neuronal ceroid lipofuscinoses (NCLs), also known as Batten disease, are a group of neurodegenerative disorders. They are considered the most common of the neurogenetic storage diseases with a prevalence of 1 in 12,500 in some populations. They are associated with variable yet progressive symptoms including seizures, dementia, visual loss, and/or cerebral atrophy. In 1826, Stengel described the first patients—4 siblings in Norway. Batten made the first clinicopathologic correlation in 1903 and referred to NCL as familial cerebromacular degeneration. Batten was also the first person to differentiate NCL from Tay-Sachs disease in 1914. Vogt, Spielmeyer, Bielschowsky, and Kufs also described older patients with similar symptoms.
In 1939, Klenk discovered increased gangliosides in Tay-Sachs disease but in not juvenile amaurotic idiocy (an early name for NCL). NCL was later so named because of the accumulation of autofluorescent lipopigments resembling ceroid and lipofuscin. In 1959, Koppang described English setters with the same phenotype as patients with NCL. Although NCLs are generally autosomal recessive disorders, in 1971 Boehme also described autosomal dominant inheritance of the same disease in the Parry family of New Jersey. The enzymatic abnormalities were better defined in the 1980s and the molecular genetics have now being described in some variants of NCL. A database of NCL mutations is maintained and can be found here.
Psora is in background
SULPHUR IS THE MEDICINE
1. Generalities, heat, sensation of.
2. Generalities, emaciation.
3. Generalities, night agg.
4. Stomach, appetite, ravenous.
5. Skin, eruption, suppressed.
6. Generalities, convulsion.
Sensitive to noise and smell of food is also Psoric symptoms and under in effect of SULPHUR.
Gud evening and wish u Peace.
I just wanted a small clarification regarding the use of sulphur, where concurrent water intake after the dose result on to any adverse effects, if so then what may be the probable cause.